Nektar Therapeutics

NASDAQ:NKTR   3:59:52 PM EDT
3.46
+0.06 (+1.92%)
Earnings Announcements

Nektar Therapeutics Reports First Quarter 2022 Financial Results

Published: 05/05/2022 20:55 GMT
Nektar Therapeutics (NKTR) - Reports First Quarter 2022 Financial Results.
Q1 Loss per Share $0.49.
Q1 Revenue $24.8 Million.
Q1 Earnings per Share View $-0.68, Revenue View $24.4 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $22.79 Million
Adjusted EPS is expected to be -$0.88

Next Quarter Revenue Guidance is expected to be $29.2 Million
Next Quarter EPS Guidance is expected to be -$0.46

More details on our Analysts Page.